0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA | 
Medical News & Perspectives |  FREE ONLINE FIRST
Jennifer Abbasi
JAMA. Published online September 21, 2016. doi:10.1001/jama.2016.12103

JAMA Oncology | 
Review |  ONLINE FIRST
Polly Niravath, MD; Burcu Cakar, MD; Matthew Ellis, MB, BChir, PhD, FRCP
JAMA Oncol. Published online August 25, 2016. doi:10.1001/jamaoncol.2016.2719

JAMA Oncology | 
Viewpoint |  ONLINE FIRST
Robert Dreicer, MD, MS
JAMA Oncol. Published online August 18, 2016. doi:10.1001/jamaoncol.2016.3325

JAMA Oncology | 
Original Investigation |  Open Access ONLINE FIRST
Maria Schwaederle, PharmD; Melissa Zhao, BS; J. Jack Lee, PhD; et al.
JAMA Oncol. Published online June 06, 2016. doi:10.1001/jamaoncol.2016.2129
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.
JAMA Oncol. 2016;2(5):655-662. doi:10.1001/jamaoncol.2015.5392.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Julie E. Bauman, MD, MPH; Jennifer Grandis, MD
JAMA Oncol. 2016;2(2):178-179. doi:10.1001/jamaoncol.2015.4637.

JAMA Oncology | 
Original Investigation | 
William N. William Jr, MD; Vassiliki Papadimitrakopoulou, MD; J. Jack Lee, PhD; et al.
JAMA Oncol. 2016;2(2):209-216. doi:10.1001/jamaoncol.2015.4364.
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint | 
Gideon M. Blumenthal, MD; Elizabeth Mansfield, PhD; Richard Pazdur, MD
JAMA Oncol. 2016;2(1):13-14. doi:10.1001/jamaoncol.2015.4503.

JAMA Oncology | 
Original Investigation | 
Chau Dang, MD; Hao Guo, MS; Julie Najita, PhD; et al.
JAMA Oncol. 2016;2(1):29-36. doi:10.1001/jamaoncol.2015.3709.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Gérard Milano, PhD; Emmanuel Chamorey, PharmD, PhD; Jean-Marc Ferrero, MD, PhD
JAMA Oncol. 2016;2(1):21-22. doi:10.1001/jamaoncol.2015.3866.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Medical News & Perspectives  | 
Getting Pharmacogenomics Into the Clinic
Jennifer Abbasi
JAMA Oncology
Review  | 
The Role of Genetic Testing in the Selection of Therapy for Breast Cancer A Review
Polly Niravath, MD; Burcu Cakar, MD; Matthew Ellis, MB, BChir, PhD, FRCP
JAMA Oncology
Viewpoint  | 
Highlights in Genitourinary (Prostate) Cancer
Robert Dreicer, MD, MS
JAMA Oncology
Original Investigation  | 
Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms A Meta-analysis
Maria Schwaederle, PharmD; Melissa Zhao, BS; J. Jack Lee, PhD; et al.